V VRTX

Vertex Pharmaceuticals Inc

BIOTECHNOLOGY · HEALTHCARE

Vertex Pharmaceuticals Inc. is a leading biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the development of innovative therapies for serious diseases, primarily cystic fibrosis (CF). Renowned for its pioneering work in CF treatments, Vertex has made significant stri...

$433.54

+0.72% (+$3.10)

Volume 1.40M

52W High $507.92

52W Low $362.50

Market Cap $108.53B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

May 5, 2026 Beat

Actual: $4.47 vs. Consensus: $4.31

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q1 2026 May 5, 2026

1-Day: +0.78%

Q1 2026 May 4, 2026

1-Day: -1.28%

Q1 2026 Mar 31, 2026

1-Day: +0.16%

Q4 2025 Feb 12, 2026

1-Day: +5.69%

5-Day: +2.65%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q1'26	$2.99B	+7.8%	86.9%	38.1%	$1.03B
Q4'25	$3.23B	+10.8%	85.6%	40.3%	$1.19B
Q3'25	$3.08B	+11.0%	86.5%	38.6%	$1.08B
Q2'25	$2.96B	+12.1%	86.3%	38.8%	$1.03B
Q1'25	$2.77B	+3.1%	86.9%	22.8%	$646.3M
Q4'24	$2.91B	+15.7%	85.5%	35.2%	$913.0M
Q3'24	$2.77B	+11.6%	85.8%	40.3%	$1.05B
Q2'24	$2.65B	+6.1%	85.9%	-132.9%	-$3.59B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	May 5, 2026	$4.31	$4.37	$4.47	+3.81%	Beat
Q1 2026	May 4, 2026	$4.31	$4.39	$4.47	+3.81%	Beat
Q1 2026	Mar 31, 2026	$4.31	$4.39	$4.47	+3.81%	Beat
Q4 2025	Feb 12, 2026	$5.12	$4.70	$5.03	-1.76%	Beat
Q4 2025	Feb 4, 2026	$5.12	$5.23	$5.03	-1.76%	Missed
Q3 2025	Nov 10, 2025	$4.61	$4.69	$4.80	+4.12%	Beat
Q3 2025	Nov 3, 2025	$4.61	$4.68	$4.80	+4.12%	Beat
Q2 2025	Aug 4, 2025	$4.25	$3.61	$4.52	+6.35%	Beat
Q1 2025	May 5, 2025	$4.29	$3.65	$4.06	-5.36%	Beat
Q4 2024	Feb 10, 2025	$4.02	$3.42	$3.98	-1.00%	Beat
Q3 2024	Nov 4, 2024	$4.13	$3.51	$4.38	+6.05%	Beat
Q2 2024	Aug 1, 2024	$2.94	$3.06	-$12.83	--	Missed